BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 24012124)

  • 1. CK2 inhibitor CX4945 induces sequential inactivation of proteins in the signaling pathways related with cell migration and suppresses metastasis of A549 human lung cancer cells.
    Ku MJ; Park JW; Ryu BJ; Son YJ; Kim SH; Lee SY
    Bioorg Med Chem Lett; 2013 Oct; 23(20):5609-13. PubMed ID: 24012124
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IDH-Inhibiting Small Molecule DTDQ Inhibits Migration and Invasion of A549 Human Non-Small-Cell Lung Cancer Cells via Sequential Inactivation Of ERK and P38 Signaling Pathways.
    Park S; Lee J; Lee SY
    Cell Biochem Biophys; 2018 Jun; 76(1-2):255-263. PubMed ID: 28321613
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiotensin-(1-7) inhibits the migration and invasion of A549 human lung adenocarcinoma cells through inactivation of the PI3K/Akt and MAPK signaling pathways.
    Ni L; Feng Y; Wan H; Ma Q; Fan L; Qian Y; Li Q; Xiang Y; Gao B
    Oncol Rep; 2012 Mar; 27(3):783-90. PubMed ID: 22089256
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-metastatic effect of cantharidin in A549 human lung cancer cells.
    Kim YM; Ku MJ; Son YJ; Yun JM; Kim SH; Lee SY
    Arch Pharm Res; 2013 Apr; 36(4):479-84. PubMed ID: 23435912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined Casein Kinase II inhibition and epigenetic modulation in acute B-lymphoblastic leukemia.
    Richter A; Roolf C; Hamed M; Gladbach YS; Sender S; Konkolefski C; Knübel G; Sekora A; Fuellen G; Vollmar B; Murua Escobar H; Junghanss C
    BMC Cancer; 2019 Mar; 19(1):202. PubMed ID: 30841886
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-androgen receptor activity of apoptotic CK2 inhibitor CX4945 in human prostate cancer LNCap cells.
    Ryu BJ; Baek SH; Kim J; Bae SJ; Chang SY; Heo JN; Lee H; Lee SY; Kim SH
    Bioorg Med Chem Lett; 2012 Sep; 22(17):5470-4. PubMed ID: 22832316
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Ferulic Acid Derivative FXS-3 Inhibits Proliferation and Metastasis of Human Lung Cancer A549 Cells via Positive JNK Signaling Pathway and Negative ERK/p38, AKT/mTOR and MEK/ERK Signaling Pathways.
    Yue SJ; Zhang PX; Zhu Y; Li NG; Chen YY; Li JJ; Zhang S; Jin RY; Yan H; Shi XQ; Tang YP; Duan JA
    Molecules; 2019 Jun; 24(11):. PubMed ID: 31181779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CX4945 suppresses the growth of castration-resistant prostate cancer cells by reducing AR-V7 expression.
    Deng C; Chen J; Guo S; Wang Y; Zhou Q; Li Z; Yang X; Yu X; Zhang Z; Zhou F; Han H; Yao K
    World J Urol; 2017 Aug; 35(8):1213-1221. PubMed ID: 28105499
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined inhibition of EGFR and CK2 augments the attenuation of PI3K-Akt-mTOR signaling and the killing of cancer cells.
    Bliesath J; Huser N; Omori M; Bunag D; Proffitt C; Streiner N; Ho C; Siddiqui-Jain A; O'Brien SE; Lim JK; Ryckman DM; Anderes K; Rice WG; Drygin D
    Cancer Lett; 2012 Sep; 322(1):113-8. PubMed ID: 22387988
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CK2 inhibitor CX4945 inhibits collagen degradation of HaCaT human keratinocyte cells via attenuation of MMP-1 secretion.
    Jeon J; Lee SY
    Mol Biol Rep; 2023 Nov; 50(11):9691-9698. PubMed ID: 37658930
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting protein kinase CK2 suppresses prosurvival signaling pathways and growth of glioblastoma.
    Zheng Y; McFarland BC; Drygin D; Yu H; Bellis SL; Kim H; Bredel M; Benveniste EN
    Clin Cancer Res; 2013 Dec; 19(23):6484-94. PubMed ID: 24036851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ethanol extracts of fruiting bodies of Antrodia cinnamomea exhibit anti-migration action in human adenocarcinoma CL1-0 cells through the MAPK and PI3K/AKT signaling pathways.
    Chen YY; Chou PY; Chien YC; Wu CH; Wu TS; Sheu MJ
    Phytomedicine; 2012 Jun; 19(8-9):768-78. PubMed ID: 22464013
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apigenin inhibits cell proliferation, migration, and invasion by targeting Akt in the A549 human lung cancer cell line.
    Zhou Z; Tang M; Liu Y; Zhang Z; Lu R; Lu J
    Anticancer Drugs; 2017 Apr; 28(4):446-456. PubMed ID: 28125432
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suppression of cell invasion and migration by propofol are involved in down-regulating matrix metalloproteinase-2 and p38 MAPK signaling in A549 human lung adenocarcinoma epithelial cells.
    Wu KC; Yang ST; Hsia TC; Yang JS; Chiou SM; Lu CC; Wu RS; Chung JG
    Anticancer Res; 2012 Nov; 32(11):4833-42. PubMed ID: 23155249
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Shikonin inhibits prostate cancer cells metastasis by reducing matrix metalloproteinase-2/-9 expression via AKT/mTOR and ROS/ERK1/2 pathways.
    Chen Y; Zheng L; Liu J; Zhou Z; Cao X; Lv X; Chen F
    Int Immunopharmacol; 2014 Aug; 21(2):447-55. PubMed ID: 24905636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [CK2α Regulates the Metastases and Migration of Lung Adenocarcinoma 
A549 Cell Line through PI3K/Akt/GSK-3β Signal Pathway].
    Wu A; Li M; Mai Z; Li S; Yang Z
    Zhongguo Fei Ai Za Zhi; 2017 Apr; 20(4):233-238. PubMed ID: 28442011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inotilone from Inonotus linteus suppresses lung cancer metastasis in vitro and in vivo through ROS-mediated PI3K/AKT/MAPK signaling pathways.
    Chao W; Deng JS; Li PY; Kuo YH; Huang GJ
    Sci Rep; 2019 Feb; 9(1):2344. PubMed ID: 30787353
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-520a-3p inhibits cell growth and metastasis of non-small cell lung cancer through PI3K/AKT/mTOR signaling pathway.
    Lv X; Li CY; Han P; Xu XY
    Eur Rev Med Pharmacol Sci; 2018 Apr; 22(8):2321-2327. PubMed ID: 29762835
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological Inhibition of Casein Kinase 2 Enhances the Effectiveness of PI3K Inhibition in Colon Cancer Cells.
    Semaan C; Neilson KA; Brown B; Molloy MP
    Anticancer Res; 2018 Nov; 38(11):6195-6200. PubMed ID: 30396937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparing the efficacy and selectivity of Ck2 inhibitors. A phosphoproteomics approach.
    Borgo C; Cesaro L; Hirota T; Kuwata K; D'Amore C; Ruppert T; Blatnik R; Salvi M; Pinna LA
    Eur J Med Chem; 2021 Mar; 214():113217. PubMed ID: 33548633
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.